Skip to main content
SpringerLink
Log in

NICE provides guidance on several diseases

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. National Institute for Health and Clinical Excellence (NICE).NICE guidance recommends option for preventing arterial blood clots in people with acute coronary syndromes. Media Release: 28 Oct 2009. Available from: URL: http://www.nice.org.uk

  2. National Institute for Health and Clinical Excellence (NICE).NICE recommends topotecan for cervical cancer. Media Release: 28 Oct 2009. Available from: URL: http://www.nice.org.uk

  3. National Institute for Health and Clinical Excellence (NICE).NICE issues updated guidance on the treatment and management of depression. Media Release: 28 Oct 2009. Available from: URL: http://www.nice.org.uk

  4. National Institute for Health and Clinical Excellence (NICE).NICE issues guidance for adults with depression and chronic physical health problems. Media Release: 28 Oct 2009. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE provides guidance on several diseases. Pharmacoecon. Outcomes News 591, 8 (2009). https://doi.org/10.2165/00151234-200905910-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905910-00013

Keywords

Search

Navigation